Literature DB >> 1533768

Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.

D E Dostal1, K M Baker.   

Abstract

Angiotensin II (AII) has been reported to have direct hypertrophic actions in mammalian and avian myocardium. In this study we determined whether AII had receptor-mediated effects on stimulating cardiac hypertrophy independent of mechanical stimuli (increased cardiac afterload) in adult rats. Angiotensin II was infused into Sprague-Dawley rats for 7 and 14 days. Following this infusion, left ventricular mass indexed to body weight (LV/BW) increased 18.6 and 17.3%, respectively, compared with control (saline infused) rats. Administration of the nonpeptide AII receptor antagonist Dup 753 prevented the increase in left ventricular hypertrophy. Blockade of converting enzyme with enalapril maleate and treatment with a vasodilator had no effect on the AII-induced hypertrophy. In this animal model, the cardiac hypertrophy appeared to be independent of cardiac afterload, because normalization of blood pressure with hydralazine did not prevent the AII-induced hypertrophy. These in vivo studies indicate that AII-induced cardiac hypertrophy is mediated through AT1 angiotensin receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533768     DOI: 10.1093/ajh/5.5.276

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  36 in total

Review 1.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 2.  Diastolic dysfunction: a link between hypertension and heart failure.

Authors:  Sophie Lalande; Bruce D Johnson
Journal:  Drugs Today (Barc)       Date:  2008-07       Impact factor: 2.245

3.  Intravenous IGF-I receptor antisense reduces IGF-IR expression and diminishes pressor responses to angiotensin II in conscious normotensive rats.

Authors:  Tien Thuy Nguyen; Paul James White
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

4.  ANG II modulation of cardiac growth and remodeling in immature fetal sheep.

Authors:  Jeremy Sandgren; Thomas D Scholz; Jeffrey L Segar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-25       Impact factor: 3.619

5.  The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.

Authors:  Dorota Ptasinska-Wnuk; Slawomir A Mucha; Hanna Lawnicka; Jolanta Fryczak; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

6.  Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension.

Authors:  David E Stec; Luis A Juncos; Joey P Granger
Journal:  J Am Soc Hypertens       Date:  2016-01-30

7.  Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.

Authors:  L Hein; M E Stevens; G S Barsh; R E Pratt; B K Kobilka; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

8.  Positive inotropic action of angiotensin II in the pithed rat.

Authors:  J Zhang; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

9.  Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.

Authors:  M Brink; J Wellen; P Delafontaine
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants.

Authors:  Gabriel Dimitriou; Despina Papakonstantinou; Eleana F Stavrou; Sotirios Tzifas; Aggeliki Vervenioti; Anny Onufriou; Aglaia Athanassiadou; Stefanos Mantagos
Journal:  Respir Res       Date:  2010-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.